BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21310483)

  • 1. DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia.
    Hu J; Lin M; Liu T; Li J; Chen B; Chen Y
    Leuk Res; 2011 Aug; 35(8):1087-92. PubMed ID: 21310483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
    Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
    Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Up-regulation of Stathmin and CrkL protein expressions in adriamycin-resistant leukemia cell line K562/A02].
    Xu JP; Hu JD; Lin MH; Li J; Liu TB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1383-7. PubMed ID: 22169288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
    Hsu CY; Yung BY
    Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
    Liu WH; Yung BY
    Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
    Derenzini M; Sirri V; Trerè D; Ochs RL
    Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages.
    Wang WJ; Tang W; Qiu ZY
    Ai Zheng; 2009 Feb; 28(2):117-21. PubMed ID: 19550115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity.
    Kondo T; Minamino N; Nagamura-Inoue T; Matsumoto M; Taniguchi T; Tanaka N
    Oncogene; 1997 Sep; 15(11):1275-81. PubMed ID: 9315094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y; Liu H; Han B; Zhang JT
    Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells.
    Shen SH; Gu LJ; Liu PQ; Ye X; Chang WS; Li BS
    Chin Med J (Engl); 2008 Mar; 121(5):463-8. PubMed ID: 18364123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of macrophages stimulated by lipopolysaccharide: Lipopolysaccharide inhibits the cleavage of nucleophosmin.
    Zhang X; Kuramitsu Y; Fujimoto M; Hayashi E; Yuan X; Nakamura K
    Electrophoresis; 2006 Apr; 27(8):1659-68. PubMed ID: 16609939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.
    Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC
    Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C23 interacts with B23, a putative nucleolar-localization-signal-binding protein.
    Li YP; Busch RK; Valdez BC; Busch H
    Eur J Biochem; 1996 Apr; 237(1):153-8. PubMed ID: 8620867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.